Table 3.
Summary of key antoprometric, metabolic and hepatic variables
| Parameter | W0 | W48 | p |
|---|---|---|---|
| Weight (kg) | 128.3 ± 26.4 | 101.0 ± 21.8 | < 0.01 |
| Waist (cm) | 126.5 ± 16.9 | 102.3 ± 14.8 | < 0.01 |
| GOT (U/L) | 28.4 ± 21.2 | 22.6 ± 7.0 | < 0.01 |
| GPT (U/L) | 35.9 ± 32.4 | 21.4 ± 8.8 | < 0.01 |
| gGT (U/L) | 35.1 ± 31.2 | 25.2 ± 16.4 | < 0.01 |
| Cholesterol (mg/dL) | 200.2 ± 45.2 | 186.5 ± 38.2 | < 0.01 |
| Triglycerides (mg/dL) | 138.9 ± 55.8 | 105.3 ± 53.3 | < 0.01 |
| Glucose (mg/dL) | 94.3 ± 29.9 | 81.7 ± 12.9 | < 0.01 |
| M30 (U/L) | 206.4 ± 168.0 | 167.3 ± 147.7 | < 0.01 |
| FLI | 93.8 ± 12.3 | 62.6 ± 29.3 | < 0.01 |
| NFS | − 0.8 ± 1.6 | − 1.6 ± 1.3 | < 0.01 |
A summary of key antoprometric, metabolic and hepatic variables is given for the per protocol cohort (n = 114) and changes over time are given. p values were calculated in paired analysis (t tests)